SCHEMBL25850549

SCHEMBL25850549

CCC(C)C1CCN(C(C)C)CC1(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24942060 0.87 — —
SCHEMBL25091877 0.86 — —
SCHEMBL20982239 0.82 — —
SCHEMBL26445266 0.82 — —
SCHEMBL24848325 0.82 — —
SCHEMBL24941857 0.76 — —
SCHEMBL25443994 0.76 — —
SCHEMBL25089971 0.75 — —
SCHEMBL13252742 0.75 HRH3 (0.31) —
SCHEMBL24865901 0.74 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691972-B2 Compounds for targeted degradation of BRD9 C4 THERAPEUTICS, INC. (US) 2023-07-04 — — US disclosed
Send feedback